UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway
Abstract Background Hepatocellular carcinoma (HCC) is highly malignant with a dismal prognosis, although the available therapies are insufficient. No efficient ubiquitinase has been identified as a therapeutic target for HCC despite the complicating role that of proteins ubiquitination plays in the...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2024-05-01
|
| Reeks: | BMC Cancer |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12885-023-11317-z |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|